Single center phase II clinical study for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation treated with Ruxolitinib and glucocorticoid
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Corticosteroids (Primary) ; Ruxolitinib (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 04 Aug 2020 New trial record